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Abstract
Introduction: Cigarette smoking and cannabis use are heritable traits and share, at least in part, 
a common genetic substrate. In recent years, the prevalence of alternative methods of nicotine 
intakes, such as electronic cigarette (e-cigarette) and water pipe use, has risen substantially. We 
tested whether the genetic vulnerability underlying cigarettes smoking and cannabis use explained 
variability in e-cigarette and water pipe use phenotypes, as these vaping methods are alternatives 
for smoking tobacco cigarettes and joints.
Methods: On the basis of the summary statistics of the International Cannabis Consortium and the 
Tobacco and Genetics Consortium, we generated polygenic risk scores (PRSs) for smoking and 
cannabis use traits, and used these to predict e-cigarette and water pipe use phenotypes in a sam-
ple of 5025 individuals from the Netherlands Twin Register.
Results: PRSs for cigarettes per day were positively associated with lifetime e-cigarette use and 
early initiation of water pipe use, but only in ex-smokers (odds ratio = 1.43, R2 = 1.56%, p = .011) and 
never cigarette smokers (odds ratio = 1.35, R2 = 1.60%, p = .013) respectively.
Conclusions: Most associations of PRSs for cigarette smoking and cannabis use with e-cigarette and 
water pipe use were not significant, potentially due to a lack of power. The significant associations 
between genetic liability to smoking heaviness with e-cigarette and water pipe phenotypes are in line 
with studies indicating a common genetic background for substance-use phenotypes. These associa-
tions emerged only in nonsmokers, and future studies should investigate the nature of this observation.
Implications: Our study showed that genetic vulnerability to smoking heaviness is associated with 
lifetime e-cigarette use and age at initiation of water pipe use. This finding has implications for the 
current debate on whether alternative smoking methods, such as usage of vaping devices, predis-
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Introduction
In recent years, the prevalence of use of non-cigarette tobacco products 
and vaporizers has risen substantially in western countries. Particularly, 
water pipe (also known as hookah, shisha, or narghile) and electronic 
cigarettes (e-cigarettes or e-cigs) have become increasingly popular.1 
These two smoking (vaping) methods have very different backgrounds. 
Water pipe use dates back to around the 18th century2 and was typic-
ally used in middle-eastern countries by adult males during social gath-
erings. Recently, this habit has also become common among younger 
people in western countries and across sexes. Nowadays, bars and 
lounges where one can smoke water pipes can be found in most cities 
in Europe and the United States. In contrast, e-cigarettes have appeared 
on the market only in recent times (see Pepper and Eissenberg1) and 
for different reasons. These electronic devices have been marketed as 
a way to quit (or as a healthier substitute to) smoking conventional 
cigarettes. Importantly, however, although e-cigarettes are advertised as 
a method to overcome dependence on conventional cigarettes, mixed 
findings have been presented in the literature in this regard, with pre-
liminary evidence also suggesting that e-cigarette use may be a gateway 
for tobacco cigarettes initiation.3,4
Despite the difference in timelines and historical background, 
these two vaping methods are similar in that they both lead to the 
inhalation of nicotine, along with some intoxicants contained in 
regular tobacco cigarettes.5,6 In addition, both methods can be used 
to consume different types of (psychoactive) substances, such as can-
nabis, and although for water pipe it is a known practice, this seems 
to be an emerging trend for e-cigarettes as well.7
Twin studies show moderate-to-high heritability estimates for 
substance use–related phenotypes, which partly share their genetic 
makeup (for a review see Agrawal et  al.8). Heritability estimates 
for smoking initiation and dependence have been estimated to be 
44% and 75%, respectively.9 For lifetime cannabis use and canna-
bis dependence, heritability estimates are around 45% and 55%, 
respectively.10 Twin studies also indicate that shared genetic influ-
ences underlie cannabis and tobacco use (r =  .31) and, even more 
consistently, cannabis and tobacco dependence (r  =  .56).11 A  gen-
etic risk prediction study have further outlined that polygenic risk 
scores (PRSs) for cigarette smoking are associated with cannabis use, 
also suggesting shared common genetic factors.12 Using results from 
large genetic consortia, substantial genetic correlations between sev-
eral substance-use phenotypes, including smoking and cannabis use, 
were found.13 Particularly notable in this regard was a genetic cor-
relation of .83 between lifetime cannabis use and smoking initiation.
Similarly, relatively novel addictive behaviors such as e-cigarette and 
water pipe use might also be heritable and share genetic factors with 
cigarette smoking and cannabis use. This seems plausible as current cig-
arette smoking is the strongest predictor of e-cigarette use, as outlined 
by a recent meta-analysis.14 There is also evidence that e-cigarette use is 
associated with cannabis initiation and water pipe use (both among cig-
arette smokers and nonsmokers15,16). Likewise, consistent evidence has 
linked water pipe use to both cigarettes and cannabis use.17–19
A well-established methodology to investigate shared genetic 
liability between traits is by creating a PRS for one trait, using 
the estimated effect sizes from a large discovery sample, and then 
investigate whether this risk score can predict another trait in an 
independent target sample.20,21 PRSs represent the genetic load an 
individual carries regarding a specific trait. In this study, we aimed to 
determine to what extent the genetic vulnerability to cigarette smok-
ing and cannabis use accounts for the variability in e-cigarette and 
water pipe use. To this purpose, we used summary-level data from 
the International Cannabis Consortium (ICC22) and the Tobacco 
and Genetic Consortium (TAG23) to generate PRSs in an independ-
ent sample of 5025 individuals registered at the Netherlands Twin 
Register (NTR). We tested the association of PRSs for smoking ini-
tiation, cigarettes per day (CPD), and lifetime cannabis use with 
e-cigarette and water pipe use characteristics. An association of the 
genetic liability for cigarette smoking and cannabis use with e-ciga-
rettes and water pipe use traits may indicate that there are common 
underlying genetic predispositions to smoking and vaping.
Methods
Discovery and Target Samples
Summary statistics were derived from the ICC22 and TAG23, which 
reported summary-level statistics of the genome-wide associ-
ation  (GWA) meta-analyses of cigarette and cannabis use pheno-
types, respectively. We used summary statistics of two smoking 
phenotypes from the TAG23: (1) smoking initiation, defined as ever 
versus never been a regular smoker (having smoked ≥100 cigarettes 
during lifetime versus having smoked fewer than 100 cigarettes 
during lifetime), and (2) CPD, operationalized as the average or 
maximum number of CPD (depending on the cohort). The single 
nucleotide polymorphism (SNP) effects we used were based on the 
meta-analytic TAG sample minus the NTR and Genetic Association 
Information Network samples, resulting in sample size of N = 69 
207 for smoking initiation and N =35 173 for CPD. In addition, we 
used the summary statistics of the GWA meta-analysis for lifetime 
cannabis use (defined as ever versus never used cannabis during life-
time) of the ICC. The SNP effects we used were based on the meta-
analytic ICC sample minus the NTR sample, resulting in a sample 
size of N = 27 677.
The target sample consisted of people registered at the NTR who 
participated in the 10th wave of the longitudinal survey study for 
adult participants and have provided a DNA sample.24–26 In the 10th 
survey for adult participants (2013–2014), information regarding 
cigarette smoking and cannabis use as well as e-cigarette and water 
pipe use was collected in adult twins and their family members of 
18 years and older. TAG and ICC summary statistics are publicly 
available data; NTR data are available through request via the NTR 
Web site (http://www.tweelingenregister.org/).
Phenotype Data
Smoking status was based on two questions: “Have you ever 
smoked?” (with answer categories: no; a few times just to try; yes), 
and “How often do you smoke now?” (with answer categories: I do 
not smoke regularly; I  have quit smoking; I  smoke <1  day/week; 
I smoke a few days per week but not daily; I smoke daily). Answers 
on these questions were combined and participants were categorized 
into never-smokers (never smoked, or a few times to try), ex-smokers 
(ever smoked, but have quit smoking), or current smokers (non-daily 
and daily smokers). To assess cannabis use, participants were asked 
the following question: “Have you ever used cannabis? We are refer-
ring to hash, weed, marijuana, a joint or space cake” (with answer 
categories of no; yes, occasionally; and yes, regularly). Lifetime can-
nabis use was analyzed as a dichotomous variable and coded as 
0 = never users versus 1 = ever users.
Questions regarding e-cigarette use and water pipe use were 
“Have you ever tried one of the following substances, devices, etc. 
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(‘yes’ or ‘no’)?”, followed by a list including e-cigarettes (with nico-
tine) and water pipe. If the question was answered affirmatively, the 
follow-up questions were “at what age for the first time?” and “have 
you used it in the past year?” (yes or no), and if used in the past 
year, “how many times?” Phenotypes investigated in this study were 
lifetime e-cigarette and water pipe use as well as age at initiation 
of water pipe use (ie, age at which respondent used water pipe for 
the first time). “Age at initiation” for e-cigarette was not included in 
the analysis as this product is on the market only for a few years. 
We also did not include the variable “used in past year” (yes vs. 
no) for both e-cigarette and water pipe, because it paralleled/over-
lapped largely with responses on the lifetime use item. The variables 
“frequency of use in past year” for both e-cigarettes and water pipe 
were excluded, as the sample sizes for these variables were too small 
(N = 129 and N = 182, respectively). A flowchart of available data 
is depicted in Supplementary Figure 1. Complete genotypic data for 
subjects with water pipe and/or e-cigarette traits and covariates were 
available for N = 5025 individuals.
Of the total sample, 66.2% individuals were female and the age 
range was 18–88 years (M = 45, SD = 16). Age at first water pipe 
was reported by 771 participants, but five individuals reported to 
have used before they were 10 years old and were set as missing. 
After individuals were excluded, age at initiation ranged from 11 to 
63 years. Age at water pipe use was subsequently split by its median 
(Mdn = 20) as to reflect early (1) versus late onset (0) water pipe ini-
tiation. Also, information on current and past cigarette smoking and 
on cannabis use was available (see Treur et al.26). Sample sizes for 
all variables are shown in Table 1, and an overview of the mean and 
median ages per subgroup is presented in Supplementary Table 1.
Polygenic Risk Scores
SNP data were available from genome-wide SNP arrays, col-
lected within the NTR through several projects between 2004 and 
2008.27,28 Genotyping was performed across different platforms, that 
is, the Perlegen-Affymetrix, Affymetrix 6.0, Illumina 660, and 1M.29 
After pre-imputation quality control (QC, see Abdellaoui et  al.28), 
data were cross-platform imputed against a Dutch reference set 
(Genome of the Netherlands, GONL) so that the SNPs missing per 
platform could be inferred.30,31 Stringent post-imputation quality 
thresholds were used.32 Only SNPs with an imputation quality score 
above 0.95 were retained; SNPs were removed if they had a minor 
allele frequency less than 0.05 or deviated from Hardy–Weinberg 
equilibrium with p less than .001. Individuals were excluded if their 
genotype missing rate was greater than 10%, if they had excess 
genome-wide homozygosity, or if they were of non-Dutch ancestry.32 
All SNPs that survived QC (N = 1 224 793) were used to construct 
polygenic scores. Detailed information on DNA collection, genotyp-
ing, genetic QC, and imputation is available elsewhere.27,28
We used SNP effect sizes from the summary statistics to gen-
erate PRS for smoking initiation, CPD, and lifetime cannabis use. 
PRSs were calculated using LDpred,33 a Bayesian approach that has 
been shown to have increased predictive accuracy compared to other 
methods. LDpred computes SNP weights based on their effect size 
estimates, their linkage disequilibrium (LD) with other SNPs (deter-
mined using a reference panel), and the degree of polygenicity of 
the trait, quantified as the expected fraction of causal markers con-
tributing to the trait. The reference panel used to determine linkage 
disequilibrium structure consisted of European populations of the 
1000 Genomes project. Multiple LDpred risk scores were calculated 
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fractions for causal markers (0.0001, 0.0003, 0.001, 0.003, 0.03, 
0.01, 0.1, and 1), representing the expected degree of polygenicity 
in the trait (eg, 0.01 = 1%). The computed PRSs were standardized.
Statistical Analysis
Prediction analyses were carried out using generalized estimation 
equations with a logit link function. To account for familial related-
ness, this method uses an exchangeable covariance matrix, allowing 
for correlated residuals between family members.34 Analyses were 
run using robust standard errors for the parameter estimates. Sex, 
age, and 10 genetic principal components were included as covari-
ates in all analyses. Principal components were included to correct 
for effects of population stratification. Depending on which PRS we 
analyzed (smoking initiation, CPD, or lifetime cannabis use) the cor-
responding phenotypic trait was controlled for in analyses: either 
ever versus never cigarette smokers, current cigarette smokers versus 
ex-smokers versus never-smokers, or ever versus never cannabis use, 
respectively. Subsequently, analyses were carried out separately for 
these groups in order to test whether genetic liability was differen-
tially expressed. Estimates of the explained variance (Nagelkerke’s 
pseudo-R2) were obtained from logistic regressions by subtracting 
the pseudo-R2 estimates of the model with covariates only from 
those including PRSs. Analyses were performed in SPSS version 22.
Results
Prevalence
Approximately 5% of the sample reported to have used e-cigarettes 
in their lifetime, whereas up to 20% reported to have tried water 
pipe at least once (Table 1). The mean age of first water pipe use was 
24.0 years (SD 9.6, Mdn = 20). The mean age of first e-cigarettes use 
was much higher (35.4, SD = 13.1, Mdn = 34, mean age when com-
pleting the survey 37.3 [SD = 13.3]) because e-cigarettes have been 
only available on the market for a limited number of years. In 76.8% 
of the e-cigarette users, the difference between their age at first use 
and their current age is 2 years or less.
The prevalence of lifetime e-cigarette and water pipe use was 
higher in current cigarette smokers (25% and 33%, respectively) 
than in ex-smokers (4% and 17%) and never-smokers (1% and 
17%). Likewise, lifetime cannabis users were more likely to have 
ever tried e-cigarettes (11%) and water pipe (41%) compared to 
never cannabis users (2% and 11% respectively). Of the total sam-
ple, 1.9% of individuals had used both e-cigarette and water pipe at 
least once in their life.
Associations of PRSs With Their Corresponding Traits
Associations of the PRSs with the corresponding traits (eg, PRSs for 
smoking initiation with smoking initiation) were tested to find the 
fraction with the highest prediction accuracy (ie, highest variance 
explained), which would then be used in our main analyses (see 
Vilhjálmsson et al.33). PRSs for smoking initiation were significantly 
associated with smoking initiation at all fractions above 0.001 with 
the highest variability accounted for by the 0.1 fraction (as well as 
the 1 fraction, because they were 100% correlated). Likewise, PRSs 
for CPD were significantly associated with smoking heaviness (CPD) 
at all fractions above 0.0001, with the highest variability explained 
by the 0.01 fraction. Finally, the PRSs for lifetime cannabis use 
showed significant associations with lifetime cannabis use at all frac-
tions above 0.0003, with the highest variability accounted for by 
the 0.1 fraction (as well as the 1 fraction). Supplementary Figure 2 
in Supplementary Material depicts variance explained by all PRSs. 
Later (Table 2) we report association tests for PRSs based on the 
0.1 fraction for smoking initiation and lifetime cannabis use, and 
on the 0.01 fraction for CPD, as these showed the highest predict-
ive accuracy with the corresponding traits. Bivariate correlations 
between these PRSs fractions showed significant positive associa-
tions between PRS for smoking initiation and PRS CPD (r = .03, p 
< .05), and between PRS for smoking initiation and PRS for lifetime 
cannabis use (r = .09, p < .0001), but not between PRS CPD and PRS 
for lifetime cannabis use (r = −.01, p > .05).
Association of PRS for Smoking Initiation With 
E-Cigarette and Water Pipe Use
No significant associations were evident between PRS for smoking 
initiation (fraction 0.1) and any of the three phenotypes considered 
(Table 2). This null finding was also consistent across other fractions 
Table 2. Associations of Polygenic Risk Scores for Smoking Initiation (Fraction 0.1), Cigarettes Per Day (Fraction 0.01), and Lifetime 
Cannabis Use (Fraction 0.1), With E-Cigarette/Water Pipe Use Phenotypes for the Total Sample, and for the Sample Stratified for Exposure 
vs Unexposure to the Covariate of Interest (ie, Ever vs. Never-Smokers, Current vs. Ex- vs. Never-Smokers, and Ever vs. Never Cannabis 
Users)
Total sample Exposed Unexposed
N Odds ratio p N Odds ratio p N Odds ratio p
PRS smoking initiation Ever-smokers Never-smokers
Lifetime e-cigarette use 4050 0.98 .839 1489 1.00 .981 2561 0.81 .390
Lifetime water pipe use 4052 0.96 .418 1485 0.93 .316 2567 1.00 .992
Age at initiation water pipe use 740 1.03 .771 315 1.00 .998 425 1.03 .809
PRS CPD Current smokers Nonsmokers (ex-/never-smokers)
Lifetime e-cigarette use 4050 1.20 .022 538 1.17 .136 951/2561 1.43/1.03 .011*/.888
Lifetime water pipe use 4052 0.96 .438 534 0.98 .844 951/2567 0.94/0.96 .505/.450
Age at initiation water pipe use 740 1.16 .098 170 0.84 .379 145/425 1.10/1.35 .638/.013*
PRS lifetime cannabis use Ever cannabis users Never cannabis users
Lifetime e-cigarette use 4128 1.14 .139 1228 1.08 .456 2900 1.21 .184
Lifetime water pipe use 4132 0.97 .552 1229 1.03 .611 2903 0.92 .245
Age at initiation water pipe use 762 1.10 .234 473 1.13 .249 289 1.17 .262
CPD = cigarettes per day, PRS = polygenic risk scores.
Bold: p < .05; *p < .017 (Bonferroni correction 0.05/3)
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Figure 1. Associations of polygenic risk scores (PRSs) for cigarettes per day (CPD) with lifetime e-cigarette use in the total sample (N = 4050) and stratified for 
current smokers (N = 538) vs. ex-smokers (N = 951) vs. never-smokers (N = 2561). Polygenic scores were calculated for eight different fractions of causal markers, 
ranging from 0.0001 to 1. *p < .05.
(Supplementary Tables 2–4). This was true also when the sample was 
stratified for lifetime cigarette smoking (ie, ever vs. never cigarette 
smoking).
Association of PRS for CPD With E-Cigarette and 
Water Pipe Use
We found positive associations between PRS for CPD and lifetime 
e-cigarette use, indicating that individuals with a higher genetic pre-
disposition for smoking more CPD were more likely to have ever 
tried e-cigarettes (fraction 0.01: odds ratio [OR] = 1.20, R2 = 0.40%, 
p = .022; see Table 2). This trend was observed for all the fractions 
above 0.0003 (.022 < p < .042, Figure 1; Supplementary Table 5), 
with the risk scores explaining a maximum of 0.40% of the vari-
ance in lifetime e-cigarette use. When the sample was stratified for 
current versus ex-smokers versus never (cigarette) smokers, this 
association seemed to be only significant in ex-smokers (OR = 1.43, 
R2  =  1.56%, p  =  .011) and not in current smokers (OR  =  1.17, 
R2  =  0.69%, p  =  .136) nor in never-smokers (OR  =  1.03, R2 < 
0.01%, p = .888).
No significant associations were observed between PRS for CPD 
(fraction 0.01) and lifetime water pipe use or age at initiation of 
water pipe use (Table 2 and Supplementary Tables 6 and 7). However, 
when the sample was stratified for current versus ex- versus never 
(cigarette) smokers, a positive association emerged between PRS 
for CPD and age at initiation of water pipe in never-smokers only 
(OR = 1.35, R2 = 1.60%, p = .013, Table 2). The results across all 
fractions (see Supplementary Table 7 and Figure 2) indicate that the 
PRS explained up to 1.90% of the variance in age at initiation of 
water pipe use.
Association of PRS for Lifetime Cannabis Use With 
E-Cigarette and Water Pipe Use
No significant associations were evident between the PRS (fraction 
0.1) for lifetime cannabis use and any of the phenotypes considered, 
even when the sample was stratified for lifetime cannabis use (ie, ever 
vs. never cannabis use; Table 2). However, when considering the low-
est fractions (fraction 0.001 and smaller, see Supplementary Table 8), 
a significant positive association with early initiation of water pipe 
was evident in the total sample. This, indicated that the higher the 
genetic predisposition to lifetime cannabis use, the more likely an 
individual was to start using water pipe at an early age, with the 
strongest association at fraction 0.0003 (OR = 1.21, R2 = 0.85%, 
p =  .018). When analyses were stratified for lifetime cannabis use, 
the association only held for those who never used cannabis (frac-
tion 0.0003, OR = 1.50, p =  .008), with up to 2.89% of variance 
explained by the lowest PRSs fractions. See also Supplementary 
Tables 9 and 10 for results across all fractions and Supplementary 
Tables 11–19 for descriptive statistics of the PRSs per groups.
Discussion
In this study, we examined whether the genetic liability underlying 
cigarette smoking and cannabis use explained variability in e-cig-
arette and water pipe use. Only the genetic liability for number of 
CPD was significantly associated with lifetime e-cigarette use and 
with early water pipe initiation. This finding is in line with other 
studies indicating a common genetic background for substance-use 
phenotypes8 and consistent with evidence suggesting that differ-
ent smoking methods tend to co-occur. However, we did not find 
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significant associations between genetic vulnerability for smoking 
initiation or cannabis use with the use of e-cigarettes. Interestingly, 
the association between the PRS for CPD with alternative smoking 
methods seems to hold only in ex-smokers for e-cigarettes and only 
in never smokers for early water pipe initiation. The explanation 
for this observation is unclear. We could speculate that these asso-
ciations might in fact underlie an overall vulnerability for addictive, 
smoking-related, behaviors. Although in (tobacco cigarette) smokers 
this predisposition leads to smoking more CPD (compared to indi-
viduals with a low genetic predisposition for CPD), in nonsmokers 
such genetic liability may find its expression in alternative smok-
ing methods (ie, use of e-cigarettes in ex-smokers and early initia-
tion of water pipe use in never-smokers). The same pattern was also 
observed in never cannabis users with a higher genetic vulnerability 
for cannabis use having higher odds to use water pipe, although only 
for the smallest PRSs fractions. Both cigarettes and the alternatives 
(e-cigarettes, water pipe) often contain nicotine, and from large 
genetic studies to cigarette smoking, it is clear that genetic variation 
in nicotine acetylcholine receptors is strongly associated with the 
number of CPD.23 This set of genes could also be involved in addic-
tive, smoking-related behaviors such as e-cigarette or water pipe use.
The observed associations could also reflect a more general per-
sonality trait, such as impulsivity, risk-taking behavior, or sensation-
seeking, which are often associated with substance-use and addictive 
behavior.35–39 Other behavioral traits, for example gambling, risky 
sexual behavior, and mental health traits (conduct disorder, antisocial 
behavior), are likely also related to this “personality profile,” which 
may have a common genetic basis. For example, the CADM2 gene is 
associated with lifetime cannabis use40 but is also associated with risk 
behavior,41 alcohol use,42and personality.43 Other mechanisms may 
also play a role, such as epigenetic factors or environmental factors.
Variance explained by the PRSs was generally low (varying from 
0.37% to 2.89%), but consistent with other PRS studies of addic-
tive phenotypes.12,44,45 Explained variance is expected to increase as 
GWAS sample sizes grow. No associations were found for the PRS 
for smoking initiation with any of the outcome variables, with the 
exception of a single significant association at fraction 0.001, which 
may be a false positive. These overall nonsignificant associations for 
the PRS for smoking initiation are in line with previous findings in a 
partly overlapping sample,12 in which the PRS for smoking initiation 
was not a good predictor of other substance-use phenotypes.
Previous research indicated that exposure to cigarette smoking or 
cannabis might causally influence e-cigarette or water pipe use,14,17 
with some studies also pointing to reverse causation (eg, e-cigarette 
use leading to cigarettes smoking, see also Bunnell et al.3 and Fielder 
et al.18). It is likely that our findings represent both (environmental) 
causality and shared genetic liability. On the one hand, we found 
associations between genetic vulnerability to CPD and e-cigarette use 
in ex-smokers, which seems to suggest a causal link between smoking 
and e-cigarette use. On the other hand, the association of PRSs for 
CPD with age at initiation of water pipe use in never-smokers seems 
to indicate a shared genetic architecture underlying these traits.
Several limitations should be taken into account when consider-
ing these results. First, in some instances statistical power may have 
been limited (especially after stratifying for smoking status or life-
time cannabis use), which may explain the many null findings in our 
article. Power analyses for the nine main analyses are provided in the 
Supplementary Material. Estimated statistical power varied consid-
erably between the different discovery and target traits (due to dif-
ferences in sample size, and prevalence rates of case–control traits) 
and was also largely dependent on the estimated genetic correlation 
between the discovery and target trait as well as the SNP-based 
Figure 2. Associations of polygenic risk scores (PRSs) for cigarettes per day (CPD) with age at initiation of water pipe use in the total sample (N = 740) and 
stratified for current smokers (N = 170) vs. ex-smokers (N = 145) vs. never-smokers (N = 425). Polygenic scores were calculated for eight different fractions of 
causal markers, ranging from 0.0001 to 1. *p < .05.
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heritability estimates of these traits. For this reason, we also had to 
exclude continuous measures of frequency of use in the past year, as 
the sample size for these variables precluded power for meaningful 
statistical testing. Second, we generated PRSs using summary-level 
data from the TAG and ICC meta-analyses, which are the largest 
GWA meta-analyses for smoking and cannabis phenotypes to date. 
However, increased accuracy in the estimation of SNPs effect sizes 
may be derived by even larger discovery sets in the future.46 Overall, 
larger discovery sets, better phenotyping, and novel statistical meth-
ods may help overcoming the present limitations.
This is the first study exploring whether genetic vulnerability 
underlying cigarette smoking and cannabis use might explain vari-
ability in e-cigarette and water pipe phenotypes. The majority of 
associations of PRSs for cigarette smoking and cannabis use with 
e-cigarette and water pipe use were not significant. The significant 
associations are in line with studies indicating a common genetic 
background for substance-use phenotypes. Future studies should 
investigate the etiology of this observation. Given the exploratory 
nature of this study, the present findings must be considered as pre-
liminary rather than conclusive.
Supplementary Material
Supplementary data are available at Nicotine and Tobacco Research online
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